Article Text

Download PDFPDF
Recent advances in hypertension in sub-Saharan Africa
  1. Okechukwu S Ogah1,2,
  2. Brian L Rayner3
  1. 1Division of Cardiovascular Medicine, Department of Medicine, University College Hospital, Ibadan, Oyo, Nigeria
  2. 2Office of the Commissioner for Health, Ministry of Health, Nnamdi Azikiwe Secretariat, Umuahia, Abia State, Nigeria
  3. 3Division of Nephrology and Hypertension, Department of Medicine, University of Cape Town and Groote Schuur Hospital, E13 Groote Schuur Hospital, Cape Town, South Africa
  1. Correspondence to Dr Okechukwu S Ogah, Division of Cardiovascular Medicine, Department of Medicine, University College Hospital, Ibadan PMB 5116, Nigeria; Ministry of Health, Nnamdi Azikiwe Secretariat, Umuahia, Abia State PMB 7215, Nigeria; osogah56156{at}


Background Hypertension was once considered rare in sub-Saharan Africa (SSA), but currently it has become a widespread problem with immense socioeconomic importance. The purpose of this review is to summarise new information on hypertension in SSA that has been published since the last major review in 2008.

Methods and results A literature search was performed in Pubmed, Embase, WHO Global Cardiovascular Infobase, African Journal On-Line, and African Index Medicus using the following search criteria: hypertension, high blood pressure, and Africa/SSA. Epidemiological surveys that used the WHO STEPS approach or similar methods were also included. The overall prevalence of hypertension in SSA was estimated at 16.2% (95% CI 14.2% to 20.3%) with an estimated number of hypertensive individuals to be 74.7 million. The prevalence of hypertension varies widely from country to country. It is projected that the number of affected individuals will increase by 68% (125.5 million) by 2025. Mass migration of rural Africans to urban areas and rapid changes in lifestyle and risk factors account for the rising prevalence of hypertension.

Conclusions Proactive public health interventions at a population level need to be introduced to control the growing hypertension epidemic, and there needs to be a major improvement in access to hypertensive care for the individual. There is an important need for better epidemiological data and hypertension related outcome trials in SSA.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles